IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Joseph Harvey

As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Swiss nutrition start-up adds Evonik as manufacturing partner

GNUbiotics Sciences has signed a manufacturing agreement with Evonik Nutrition & Care for a product targeting the animal microbiome.

R&D Deals

Bimeda enters biologicals space with purchase of Texas business

Ireland's Bimeda has acquired Texas Vet Lab (TVL) and moved into the veterinary vaccine sector.

Bimeda Deals

Matthias Hofer takes over from George Gunn as Stonehaven head

Matthias Hofer has become managing partner of Stonehaven Consulting.

People Operations

Bayer's Neptra handed European marketing authorization

Bayer Animal Health has received European approval for its Neptra canine ear drop solution. 

Bayer Animal Health Pharmaceuticals

CSPI raises concerns about a sudden uptick in US sales of antimicrobials for food animals

Concerned that sales of medically important antimicrobials for food animals rose in the US rose by 9% between 2017 and 2018, one consumer group is urging FDA to further tighten safeguards by ensuring antibiotics are only prescribed for use in food animals for a limited duration and for carefully defined purposes.

US Food Policy US Agricultural Policy

US sales of medically important antimicrobials increased 9% in 2018

Sales and distribution of medically important antimicrobials for food animals in the US went up 9% between 2017 and 2018.

United States FDA
See All